Systolic pressure is all that matters

The Lancet

Volumn 371, Issue 9631, 2008, Pages 2219-2221

  Williams, Bryan ^a   Lindholm, Lars H ^b   Sever, Peter ^c  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGING; ARTERY RESISTANCE; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIASTOLIC BLOOD PRESSURE; HEALTH CARE POLICY; HUMAN; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; SYSTOLIC HYPERTENSION;

EID: 45849151306     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(08)60804-1     Document Type: Note

References (24)

1. Lewington S., Clarke R., Qizilbash N., Peto R., and Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 360 (2002) 1903-1913
2. Asia Pacific Cohort Studies Collaboration. Blood pressure indices and cardiovascular disease in the Asia Pacific region: a pooled analysis. Hypertension 42 (2003) 69-75
3. Lawes C., Vander H.S., and Rodgers A. Global burden of blood pressure related disease, 2001. Lancet 371 (2008) 1513-1518
4. Sever P. Abandoning diastole. BMJ 318 (1999) 1773
5. Stamler J., Stamler R., and Neaton J. Blood pressure, systolic and diastolic, and cardiovascular risks. US population data. Arch Intern Med 153 (1993) 598-615
6. Burt V., Whelton P., Roccella E., et al. Prevalence of hypertension in the US population. Hypertension 25 (1995) 305-313
7. Franklin S., Jacobs M., Wong N., L'Italien G., and Lapeurta P. Predominance of isolated systolic hypertension among middle aged and elderly US hypertensives: analysis based on National Health and Nutrition Examination Survey (NHANES III). Hypertension 37 (2001) 869-874
8. O'Rourke M. Mechanical principles in arterial disease. Hypertension 26 (1995) 2-9
9. Yambe M., Tomiyama H., Yamada J., et al. Arterial stiffness and progression to hypertension in Japanese male subjects with high normal blood pressure. J Hypertens 25 (2007) 87-93
10. Hansson L., Zanchetti A., Carruthers S., et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principle results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 351 (1998) 1755-1762
11. Lawes C., Vander H.S., Law M., Elliott P., MacMahon S., and Rodgers A. Blood pressure and the global burden of disease 2000. Part I: estimates of blood pressure levels. J Hypertens 24 (2006) 413-422
12. Kearney P., Whelton M., Reynolds K., Muntner P., Whelton P., and He J. Global burden of hypertension: analysis of worldwide data. Lancet 365 (2005) 217-223
13. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 265 (1991) 3255-3264
14. Dahlöf B., Lindholm L., Hansson L., Scherstén B., Ekbom T., and Wester P. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP Hypertension). Lancet 338 (1991) 1281-1285
15. Fagarrd R., Staessen J., Thijs L., et al. On-treatment diastolic blood pressure and prognosis in systolic hypertension. Arch Intern Med 167 (2007) 1884-1891
16. Beckett N., Peters R., Fletcher A., et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med 358 (2008) 1887-1898
17. Mancia G., and Grassi G. Systolic and diastolic blood pressure control in antihypertensive drug trials. J Hypertens 20 (2002) 1461-1464
18. Waeber B., and Mourad J. Targeting systolic blood pressure: the key to controlling combined systolic/diastolic hypertension. Am J Hypertens 19 (2006) 985-986
19. Vasan R., Larson M., Leip E., et al. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med 345 (2001) 1291-1297
20. WHO, and International Society of Hypertension Writing Group. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 21 (2003) 1983-1992
21. Chobanian A., Bakris G., Black H., et al. Seventh report of the Joint National Committee on the Prevention, Detection, Evaluation and Treatment of High Blood Pressure. Hypertension 42 (2003) 1206-1252
22. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). 2007 guidelines for the management of arterial hypertension. J Hypertens 25 (2007) 1105-1187
23. Higgens B., Williams B., and for the guideline development group. Pharmacological management of hypertension. Clin Med 7 (2007) 612-616
24. MacMahon S., Alderman M., Lindholm L., Liu L., Sanchez R., and Seedat Y. Blood pressure related disease is a global health priority. Lancet 371 (2008) 1480-1481